Cited by 5,228Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index, and 2 are not checked yet.

Nonalcoholic Fatty Liver Disease

Angulo, Paul·2002·New England Journal of Medicine

DOI 10.1056/nejmra011775

Open this paper in CoChat — free account

Abstract

Alcohol abuse is the most common cause of fatty liver disease, but it is now apparent that fat deposition in the liver, and its consequences, may occur without alcohol abuse. The principal risk factors are obesity, non-insulin-dependent diabetes mellitus, and hyperlipidemia. The disorder has a wide clinical spectrum, ranging from asymptomatic steatosis to steatohepatitis, fibrosis, and cirrhosis. This article provides a broad overview of this increasingly recognized liver disease.

Integrity signals

Registry

Crossref · 10.1056/nejmra011775

Cites

90 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Show all 90 references

Research works printed but not linked: 9

Schaffner F, 1986, Prog Liver Dis, 8, 283
Itoh S, 1987, Am J Gastroenterol, 82, 650
Silverman JF, 1990, Am J Gastroenterol, 85, 1349
Creutzfeldt W, 1970, Prog Liver Dis, 3, 371
Silverman JF, 1989, Pathol Annu, 24, 275
Debaere C, 1998, J Belge Radiol, 81, 174
Zatloukal K, 1991, Lab Invest, 64, 200
Curzio M, 1985, Int J Tissue React, 7, 137
Watson AM, 1999, Drug Metab Dispos, 27, 695

Sorted by citations

Items 401–500 of 1,031

Fatty liver disease in diabetes mellitus.
Bhatt, H. B., & Smith, R. J. (2015) · PubMed · doi:10.3978/j.issn.2304-3881.2015.01.03 · Cited by 216
COMMON PATHOGENIC MECHANISM IN DEVELOPMENT PROGRESSION OF LIVER INJURY CAUSED BY NON-ALCOHOLIC OR ALCOHOLIC STEATOHEPATITIS
Nagata, K., Suzuki, H., & Sakaguchi, S. (2007) · The Journal of Toxicological Sciences · doi:10.2131/jts.32.453 · Cited by 215
Effect of 6‐Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver Function
Larson‐Meyer, D. E., Newcomer, B. R., Heilbronn, L. K., Vólaufová, J., Smith, S. R., Alfonso, A. J., LeFevre, M. L., Rood, J. C., Williamson, D. A., Ravussin, É., et al. (2008) · Obesity · doi:10.1038/oby.2008.201 · Cited by 215
Morphology of Alcoholic Liver Disease
Lefkowitch, J. H. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.11.001 · Cited by 214
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent
Romeo, S., Sentinelli, F., Dash, S., Yeo, G. S. H., Savage, D. B., Leonetti, F., Capoccia, D., Incani, M., Maglio, C., Iacovino, M., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.216 · Cited by 213
Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver
Perseghin, G., Lattuada, G., COBELLI, F. D., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Maschio, A. D., et al. (2007) · Hepatology · doi:10.1002/hep.21983 · Cited by 213
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease
Suzuki, A., Angulo, P., Lymp, J. F., Li, D., Satomura, S., & Lindor, K. D. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01064.x · Cited by 213
Self-citation
Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells
Povero, D., Eguchi, A., Niesman, I. R., Andronikou, N., du Jeu, X. D. M., Mulya, A., Berk, M. P., Lazić, M., Thapaliya, S., Parola, M., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004512 · Cited by 213
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis
Polimeni, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i10.1325 · Cited by 213
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili‐Firoozinezhad, S., & Solati‐Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 213
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan
Kitamoto, T., Kitamoto, A., Yoneda, M., Hyogo, H., Ochi, H., Nakamura, T., Teranishi, H., Mizusawa, S., Ueno, T., Chayama, K., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1294-3 · Cited by 212
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M. A., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 212
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Lin, H., Yu, I.-C. I., Wang, R.-S., Chen, Y., Liu, N.-C., Altuwaijri, S., Hsu, C., Ma, W., Jokinen, J. D., Sparks, J. D., et al. (2008) · Hepatology · doi:10.1002/hep.22252 · Cited by 212
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L. V. C., Maraschi, A., Catapano, A. L., & Fargion, S. R. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 211
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist #
Cable, E. E., Finn, P. D., Stebbins, J. W., Hou, J., Ito, B. R., van Poelje, P. D., Linemeyer, D. L., & Erion, M. D. (2008) · Hepatology · doi:10.1002/hep.22572 · Cited by 211
Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register
Zimmermann, E., Gamborg, M., Holst, C., Baker, J. L., Sørensen, T. I. A., & Berentzen, T. L. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006998 · Cited by 211
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419511 · Cited by 210
Metabolic Complications of Childhood Obesity
Weiss, R., & Kaufman, F. R. (2008) · Diabetes Care · doi:10.2337/dc08-s273 · Cited by 209
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyń, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19511 · Cited by 209
Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Schmidt, C. O., Fleßa, S., & Alte, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.024 · Cited by 208
The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
Rifai, M. A., Silverman, M. G., Nasir, K., Budoff, M. J., Blankstein, R., Szklo, M., Katz, R., Blumenthal, R. S., & Blaha, M. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.011 · Cited by 208
Role of DGAT enzymes in triacylglycerol metabolism
Bhatt-Wessel, B., Jordan, T. W., Miller, J. H., & Peng, L. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.08.001 · Cited by 208
The weight of obesity on the human immune response to vaccination
Painter, S. D., Ovsyannikova, I. G., & Poland, G. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.101 · Cited by 208
Mitochondrial glutathione: Features, regulation and role in disease
Marí, M., Morales, A., Colell, A., García‐Ruiz, C., Kaplowitz, N., & Fernández-Checa, J. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.018 · Cited by 207
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
Hardwick, R. N., Fisher, C. D., Canet, M. J., Lake, A. D., & Cherrington, N. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035006 · Cited by 207
[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组 (2006) · PubMed · Cited by 207
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice
Ye, D., Li, F. Y. L., Lam, K. S. L., Li, H., Jia, W., Wang, Y., Man, K., Lo, C. M., Li, X., & Xu, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300269 · Cited by 206
Soft drinks consumption and nonalcoholic fatty liver disease
Nseir, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i21.2579 · Cited by 206
Outcome After Liver Transplantation for NASH Cirrhosis
Malik, S. M., DeVera, M., Fontes, P., Shaikh, O. S., & Ahmad, J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02590.x · Cited by 206
Occurrence, toxicity and transformation of six typical benzotriazoles in the environment: A review
Shi, Z.-Q., Liu, Y.-S., Xiong, Q., Cai, W.-W., & Ying, G.-G. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.01.138 · Cited by 205
Apoptosis in alcoholic and nonalcoholic steatohepatitis
Ariel, E. F. (2005) · Frontiers in bioscience · doi:10.2741/1765 · Cited by 205
Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis
Wang, X., Li, J., Riaz, D., Shi, G., Liu, C., & Dai, Y. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.023 · Cited by 205
Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: A systematic review from sham CPAP randomized controlled trials
Jullian‐Desayes, I., Joyeux‐Faure, M., Tamisier, R., Launois, S. H., Borel, A., Levy, P. A., & Pépin, J. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.07.004 · Cited by 205
Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
Kechagias, S., Ernersson, Å., Dahlqvist, O. L., Lundberg, P., Lindström, T., Nyström, F. H., & for the Fast Food Study Group (2008) · Gut · doi:10.1136/gut.2007.131797 · Cited by 205
Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
Jojima, T., Tomotsune, T., Iijima, T., Akimoto, K., Suzuki, K., & Aso, Y. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0169-x · Cited by 205
Abnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
Szendroedi, J., Chmelik, M., Schmid, A. I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., & Roden, M. (2009) · Hepatology · doi:10.1002/hep.23093 · Cited by 204
Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment
Carter-Kent, C. A., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01709.x · Cited by 204
Systematic review: the evidence base for long‐term management of coeliac disease
Haines, M. L., Anderson, R. P., & Gibson, P. R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03820.x · Cited by 204
Nonalcoholic Steatohepatitis in Children
Carter-Kent, C. A., Yerian, L. M., Brunt, E. M., Angulo, P., Kohli, R., Ling, S. C., Xanthakos, S. A., Whitington, P. F., Charatcharoenwitthaya, P., Yap, J. Y. K., et al. (2009) · Hepatology · doi:10.1002/hep.23133 · Cited by 203
Self-citation
Redox Control of Liver Function in Health and Disease
Marí, M., Colell, A., Morales, A., von Montfort, C., García‐Ruiz, C., & Fernández-Checa, J. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2634 · Cited by 203
Gamma‐glutamyltransferase—friend or foe within?
Kunutsor, S. K. (2016) · Liver International · doi:10.1111/liv.13221 · Cited by 203
Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study
Liu, B., Balkwill, A., Reeves, G., Beral, V., & Collaborators., O. B. O. T. M. W. S. (2010) · BMJ · doi:10.1136/bmj.c912 · Cited by 202
Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease
Alwayn, I. P. J., Gura, K. M., Nosé, V., Zausche, B., Javid, P. J., Garza, J. J., Verbesey, J. E., Voss, S. D., Ollero, M., Andersson, C., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153672.43030.75 · Cited by 202
c-Jun N-terminal Kinase-1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., Minicis, S. D., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 202
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., & Ben, M. D. (2020) · Nutrients · doi:10.3390/nu12092762 · Cited by 202
Increased production of sonic hedgehog by ballooned hepatocytes
Rangwala, F., Guy, C. D., Lu, J., Suzuki, A., Burchette, J. L., Abdelmalek, M. F., Chen, W., & Diehl, A. M. (2011) · The Journal of Pathology · doi:10.1002/path.2888 · Cited by 201
Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis
Pickhardt, P. J., Park, S. H., Hahn, L., Lee, S., Bae, K. T., & Yu, E. S. (2011) · European Radiology · doi:10.1007/s00330-011-2349-2 · Cited by 201
Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases
Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J. H., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 201
Insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian men
Park, S. H., Kim, B. I., Yun, J. W., Kim, J. W., Park, D. I., Cho, Y. K., Sung, I. K., Park, C. Y., Sohn, C. I., Jeon, W. K., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03362.x · Cited by 201
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico, L., Nobili, V., Anania, C., Verdecchia, P., & Chiesa, C. (2011) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v17.i26.3082 · Cited by 201
Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
Kıyıcı, M., Gülten, M., Gürel, S., Nak, S. G., Dolar, E., Savcı, G., Adım, Ş. B., Yerci, Ö., & Memik, F. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/857869 · Cited by 200
Nonalcoholic fatty liver disease - A multisystem disease?
Mikolašević, I., Milić, S., Wensveen, T. T., Grgić, I., Jakopčić, I., Štimac, D., Wensveen, F. M., & Orlić, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i43.9488 · Cited by 200
Advanced MRI Methods for Assessment of Chronic Liver Disease
Taouli, B. A., Ehman, R. L., & Reeder, S. B. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.09.2601 · Cited by 199
Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet
Feng, S., Dai, Z., Liu, A. B., Huang, J., Narsipur, N., Guo, G. L., Kong, B., Reuhl, K. R., Lu, W., Luo, Z., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.004 · Cited by 198
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
Angulo, P., Alba, L. M., Petrovic, L. M., Adams, L. A., Lindor, K. D., & Jensen, M. D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.020 · Cited by 198
Self-citation
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Park, H., Shima, T., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., Yoshikawa, T., Fukui, M., Hasegawa, G., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0291-8 · Cited by 197
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms
Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., & Meli, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.002 · Cited by 197
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
Targher, G., Bertolini, L., Padovani, R., Zenari, L., Zoppini, G., & Falezza, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2498 · Cited by 197
A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels
Stefanović-Račić, M., Perdomo, G., Mantell, B. S., SIPULA, I. J., Brown, N. F., & O'Doherty, R. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2007 · Cited by 197
Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects
Kotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Cornér, A., Bergholm, R., & Yki-Järvinen, H. (2008) · Diabetes Care · doi:10.2337/dc07-1463 · Cited by 196
Curcumin and Liver Disease: from Chemistry to Medicine
Nabavi, S. F., Daglia, M., Moghaddam, A. H., Habtemariam, S., & Nabavi, S. M. (2013) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12047 · Cited by 196
Chronological development of elevated aminotransferases in a nonalcoholic population
Suzuki, A., Angulo, P., Lymp, J. F., Sauver, J. L. S., Muto, A., Okada, T., & Lindor, K. D. (2004) · Hepatology · doi:10.1002/hep.20543 · Cited by 196
Self-citation
The Inflammatory C-Reactive Protein Is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASH
Anty, R., Bekri, S., Luciani, N., Saint‐Paul, M., Dahman, M., Iannelli, A., Amor, I. B., Staccini-Myx, A., Huet, P., Gugenheim, J., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00724.x · Cited by 196
Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
Dixon, L. J., Flask, C. A., Papouchado, B. G., Feldstein, A. E., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056100 · Cited by 195
Cell-to-Cell Heterogeneity in Lipid Droplets Suggests a Mechanism to Reduce Lipotoxicity
Herms, A., Bosch, M., Ariotti, N., Reddy, B. J. N., Fajardo, A., Fernández‐Vidal, A., Álvarez-Guaita, A., Fernandez-Rojo, M. A., Rentero, C., Tebar, F., et al. (2013) · Current Biology · doi:10.1016/j.cub.2013.06.032 · Cited by 195
The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis
Sugimoto, K., Moriyasu, F., Oshiro, H., Takeuchi, H., Abe, M., Yoshimasu, Y., Kasai, Y., Sakamaki, K., Hara, T., & Itoi, T. (2020) · Radiology · doi:10.1148/radiol.2020192665 · Cited by 195
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J. M., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 195
Increased Serum Resistin in Nonalcoholic Fatty Liver Disease Is Related to Liver Disease Severity and Not to Insulin Resistance
Pagano, C., Soardo, G., Pilon, C., Milocco, C., Basan, L., Milan, G., Donnini, D., Faggian, D., Mussap, M., Plebani, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1056 · Cited by 195
Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells
Lin, C., Huang, H., & Lin, J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700128-jlr200 · Cited by 194
Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
Assy, N., Djibre, A., Farah, R. E., Grosovski, M., & Marmor, A. T. (2010) · Radiology · doi:10.1148/radiol.09090769 · Cited by 194
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α
Han, L., Shen, W., Bittner, S., Kraemer, F. B., & Azhar, S. (2017) · Future Cardiology · doi:10.2217/fca-2016-0059 · Cited by 194
Non-alcoholic steatohepatitis: From cell biology to clinical practice
Cortez‐Pinto, H., de Moura, M. C., & Day, C. P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.002 · Cited by 194
A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
Harrison, S. A., Fincke, C., Helinski, D., Torgerson, S., & Hayashi, P. H. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02153.x · Cited by 194
The role of growth hormone and insulin-like growth factor-I in the liver
Takahashi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071447 · Cited by 193
Nonalcoholic fatty liver disease
Krawczyk, M. J., Bonfrate, L., & Portincasa, P. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.08.005 · Cited by 193
Non‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
Cusi, K. J., Sanyal, A. J., Zhang, S., Hartman, M. L., Bue‐Valleskey, J. M., Hoogwerf, B. J., & Haupt, A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12973 · Cited by 193
Quantification of Liver Fat Content: Comparison of Triple-Echo Chemical Shift Gradient-Echo Imaging and in Vivo Proton MR Spectroscopy
Guiu, B., Petit, J., Loffroy, R., Salem, D. B., Aho, S., Masson, D., Hillon, P., Krause, D., & Cercueil, J. (2008) · Radiology · doi:10.1148/radiol.2493080217 · Cited by 192
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
Hassan, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12082 · Cited by 192
Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
Ore, A., & Akinloye, O. A. (2019) · Medicina · doi:10.3390/medicina55020026 · Cited by 192
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cerda, C., Pérez‐Ayuso, R. M., Riquelme, A. J., Soza, A., Villaseca, P., Sir‐Petermann, T., Espinoza, M., Pizarro, M., Solís, N., Miquel, J. F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.012 · Cited by 191
Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine
Kathirvel, E., Morgan, K., Nandgiri, G., Sandoval, B. C., Caudill, M. A., Bottiglieri, T., French, S. W., & Morgan, T. R. M. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00249.2010 · Cited by 191
Olive oil consumption and non-alcoholic fatty liver disease
Assy, N., Nassar, F., Nasser, G., & Grosovski, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1809 · Cited by 190
Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
Xu, L., Kitade, H., Ni, Y., & Ota, T. (2015) · Biomolecules · doi:10.3390/biom5031563 · Cited by 190
What is the real function of the liver 'function' tests?
Hall, P., & Cash, J. (2012) · Europe PMC (PubMed Central) · Cited by 190
The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases
Tsochatzis, E. A., Papatheodoridis, G., & Archimandritis, A. J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00848.x · Cited by 190
Prospective Biopsy-Controlled Evaluation of Cell Death Biomarkers for Prediction of Liver Fibrosis and Nonalcoholic Steatohepatitis
Joka, D., Wahl, K., Moeller, S., Schlué, J., Vaske, B., Bahr, M. J., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2011) · Hepatology · doi:10.1002/hep.24734 · Cited by 189
The Role of Metformin in the Management of NAFLD
Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., & Belfiore, A. (2011) · Experimental Diabetes Research · doi:10.1155/2012/716404 · Cited by 189
Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
Zhu, F., Liu, S., Chen, X.-M., Huang, Z., & Zhang, D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6395 · Cited by 189
Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
Giorgio, V., Prono, F., Graziano, F., & Nobili, V. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-40 · Cited by 189
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
Angelico, F., Ben, M. D., Conti, R., Francioso, S., Feole, K., Maccioni, D., Antonini, T., & Alessandri, C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02958.x · Cited by 189
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
Kim, D., Chung, G. E., Kwak, M., Seo, H. B., Kang, J. H., Kim, W. K., Kim, Y. J., Yoon, J., Lee, H.-S., & Kim, C. Y. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.024 · Cited by 188
High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate–activated protein kinase
Adachi, M., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.21991 · Cited by 188
SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
Zhang, T., Liu, J., Shen, S., Tong, Q., Ma, X., & Lin, L. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0356-z · Cited by 188
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Sterling, R. K., Patel, K., Duarte‐Rojo, A., Asrani, S. K., Alsawas, M., Dranoff, J. A., Fiel, M. I., Murad, M. H., Leung, D. H., Levine, D., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000845 · Cited by 188
An apoptosis panel for nonalcoholic steatohepatitis diagnosis
Tamimi, T., Elgouhari, H. M., Alkhouri, N., Yerian, L. M., Berk, M. P., López, R., Schauer, P. R., Zein, N. N., & Feldstein, A. E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.023 · Cited by 187
Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population
Dassanayake, A. S., Kasturiratne, A., Rajindrajith, S., Kalubowila, U., Chakrawarthi, S., Silva, A. P. D., Makaya, M., Mizoue, T., Kato, N., Wickremasinghe, A. R., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05831.x · Cited by 187
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
Clark, J. M., Al-Khuraishi, A., Solga, S. F., Alli, P. M., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 187
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Larter, C. Z., Chitturi, S., Heydet, D., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06253.x · Cited by 187
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Cintra, D. E., Pauli, J. R., ARAUJO, E. P. D., Moraes, J. C., de Souza, C. T., Milanski, M., Morari, J., Gambero, A., Saad, M. J. A., & Velloso, L. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.017 · Cited by 186

Authors: Angulo, P.
Affiliations: Mayo Clinic (US)
Corresponding author: Angulo, Paul
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2002-04-18
Volume: 346
Issue: 16
Pages: 1221-1231
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra011775
OpenAlex: W2040109162
Cited by: 5,228
References: 90
Citations by year: 2026: 38 · 2025: 80 · 2024: 102 · 2023: 171 · 2022: 155 · 2021: 191 · 2020: 246 · 2019: 228 · 2018: 222 · 2017: 264 · 2016: 275 · 2015: 339 · 2014: 368 · 2013: 319 · 2012: 309
FWCI: 23.15
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic steatosis, steatohepatitis, liver fibrosis, liver cirrhosis, obesity, type 2 diabetes, hyperlipidemia, risk factors, alcohol abuse
MeSH terms: Biopsy, Fatty Liver, Humans, Liver, Liver Function Tests, Radiography, Risk Factors, Ultrasonography, Weight Loss, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Fatty Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks